Walgreens Boots Alliance Stock Forecast, Price & News

15 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Walgreens Boots Alliance in the last year. There are currently 2 sell ratings, 11 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" Walgreens Boots Alliance stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in WBA, but not buy additional shares or sell existing shares.
View analyst ratings for Walgreens Boots Alliance or view top-rated stocks.

Wall Street analysts have given Walgreens Boots Alliance a "Hold" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Walgreens Boots Alliance wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Walgreens Boots Alliance saw a increase in short interest in August. As of August 31st, there was short interest totaling 15,480,000 shares, an increase of 20.6% from the August 15th total of 12,840,000 shares. Based on an average daily trading volume, of 5,600,000 shares, the days-to-cover ratio is presently 2.8 days. Approximately 2.2% of the shares of the company are short sold.
View Walgreens Boots Alliance's Short Interest.

Walgreens Boots Alliance is scheduled to release its next quarterly earnings announcement on Thursday, October 14th 2021.
View our earnings forecast for Walgreens Boots Alliance.

Walgreens Boots Alliance will be holding an earnings conference call on Thursday, October 14th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link.

Walgreens Boots Alliance, Inc. (NASDAQ:WBA) announced its earnings results on Wednesday, June, 30th. The pharmacy operator reported $1.38 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.17 by $0.21. The pharmacy operator had revenue of $34.03 billion for the quarter, compared to analyst estimates of $33.47 billion. Walgreens Boots Alliance had a net margin of 1.66% and a trailing twelve-month return on equity of 20.79%. The company's revenue was up 12.1% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.71 earnings per share.
View Walgreens Boots Alliance's earnings history.

Walgreens Boots Alliance's stock was trading at $46.07 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, WBA stock has increased by 7.7% and is now trading at $49.62.
View which stocks have been most impacted by COVID-19.

Walgreens Boots Alliance declared a quarterly dividend on Tuesday, July 13th. Shareholders of record on Friday, August 20th will be paid a dividend of $0.477 per share on Friday, September 10th. This represents a $1.91 dividend on an annualized basis and a yield of 3.85%. The ex-dividend date is Thursday, August 19th. This is a boost from Walgreens Boots Alliance's previous quarterly dividend of $0.47.
View Walgreens Boots Alliance's dividend history.

Walgreens Boots Alliance pays an annual dividend of $1.91 per share and currently has a dividend yield of 3.82%. The dividend payout ratio of Walgreens Boots Alliance is 40.30%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Walgreens Boots Alliance will have a dividend payout ratio of 37.38% next year. This indicates that Walgreens Boots Alliance will be able to sustain or increase its dividend.
View Walgreens Boots Alliance's dividend history.

15 Wall Street analysts have issued 12-month target prices for Walgreens Boots Alliance's stock. Their forecasts range from $33.00 to $68.00. On average, they expect Walgreens Boots Alliance's share price to reach $51.59 in the next twelve months. This suggests a possible upside of 4.0% from the stock's current price.
View analysts' price targets for Walgreens Boots Alliance or view top-rated stocks among Wall Street analysts.

4,267 employees have rated Walgreens Boots Alliance CEO Stefano Pessina on Glassdoor.com. Stefano Pessina has an approval rating of 32% among Walgreens Boots Alliance's employees. This puts Stefano Pessina in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Some companies that are related to Walgreens Boots Alliance include CVS Health (CVS), Covetrus (CVET), Rite Aid (RAD), PetMed Express (PETS), 111 (YI), MedAvail (MDVL), China Jo-Jo Drugstores (CJJD), Progressive Care (RXMD), HealthWarehouse.com (HEWA), Dragon Jade International (DGJI), Dougherty's Pharmacy (MYDP), China Dasheng Biotechnology (CDBT) and Health Sciences Group (HESG).
View all of WBA's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Walgreens Boots Alliance investors own include AT&T (T), Intel (INTC), CVS Health (CVS), Johnson & Johnson (JNJ), The Walt Disney (DIS), Cisco Systems (CSCO), AbbVie (ABBV), Verizon Communications (VZ), Pfizer (PFE) and Exxon Mobil (XOM).

Walgreens Boots Alliance trades on the NASDAQ under the ticker symbol "WBA."

Walgreens Boots Alliance's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (6.81%), BlackRock Inc. (6.41%), State Street Corp (5.08%), FMR LLC (1.92%), Geode Capital Management LLC (1.35%) and Northern Trust Corp (0.99%).
View institutional ownership trends for Walgreens Boots Alliance.

WBA stock was sold by a variety of institutional investors in the last quarter, including Caisse DE Depot ET Placement DU Quebec, Bank of New York Mellon Corp, Price T Rowe Associates Inc. MD, BlackRock Inc., Susquehanna International Group LLP, State Street Corp, Bridgewater Associates LP, and LSV Asset Management.
View insider buying and selling activity for Walgreens Boots Alliance or view top insider-selling stocks.

WBA stock was purchased by a variety of institutional investors in the last quarter, including Amundi, Bank of Montreal Can, Invesco Ltd., Parametric Portfolio Associates LLC, FMR LLC, Vanguard Group Inc., Zurich Insurance Group Ltd FI, and Mn Services Vermogensbeheer B.V..
View insider buying and selling activity for Walgreens Boots Alliance or or view top insider-buying stocks.

Shares of WBA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of WBA stock can currently be purchased for approximately $49.62.

Walgreens Boots Alliance has a market capitalization of $42.92 billion and generates $139.54 billion in revenue each year. The pharmacy operator earns $456 million in net income (profit) each year or $4.74 on an earnings per share basis.

Walgreens Boots Alliance employs 277,000 workers across the globe.

The following companies are subsidiares of Walgreens Boots Alliance: Alliance Boots Holdings Limited, Alliance Healthcare (Distribution) Limited, Alliance Healthcare Deutschland AG, Alliance Healthcare Ecza Deposu Anonim Şirketi, Alliance Healthcare España S.A., Alliance Healthcare Romania SRL, Alliance Healthcare Répartition, Bond Drug Company of Illinois LLC, Boots Retail (Ireland) Limited, Boots UK Limited, Duane Reade, Farmacias Benavides S.A.B. de C.V., Liz Earle Beauty, Prime Therapeutics Specialty Pharmacy LLC, Sinopharm Holding GuoDa Drug Store Co., Superior Acquisitions Limited, Superior Holdings Limited, Superior Luxco 1 S.à r.l., Take Care Health Employer Solutions, The Boots Company PLC, United Company of Pharmacists SAE, WBA Acquisitions UK Holdco 7 Limited, WBA Acquisitions UK Topco Limited, WBA Financial LLC, WBA International Limited, WBA Investments Inc., WBA Luxembourg 6 S.à r.l., WBA Luxembourg 7 S.à.r.l., WBAD Holdings Limited, Walgreen Arizona Drug Co., Walgreen Co., Walgreen Eastern Co. Inc., Walgreen International S.à r.l., Walgreen Investments Luxembourg S.à r.l., Walgreen Louisiana Co. Inc., Walgreen of Puerto Rico Inc., Walgreens Boots Alliance (Hong Kong) Investments Limited, Walgreens Boots Alliance Holdings LLC, Walgreens Boots Alliance Limited, Walgreens Boots Alliance Scottish LP, Walgreens Specialty Pharmacy LLC, Waltrust Properties Inc., and iA.

Walgreens Boots Alliance was founded in 2014.

The official website for Walgreens Boots Alliance is www.walgreensbootsalliance.com.

Walgreens Boots Alliance is headquartered at 108 Wilmot Road, Deerfield IL, 60015.

Walgreens Boots Alliance's mailing address is 108 Wilmot Road, Deerfield IL, 60015. The pharmacy operator can be reached via phone at (847) 315-2500 or via email at [email protected]